Detalhe da pesquisa
1.
Phase 2 study of epigenetic priming with decitabine followed by cytarabine for acute myeloid leukemia in older patients.
Am J Hematol
; 99(3): 380-386, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38258329
2.
Therapy With Allogeneic Severe Acute Respiratory Syndrome Coronavirus-2-Specific T Cells for Persistent Coronavirus Disease 2019 in Immunocompromised Patients.
Clin Infect Dis
; 77(5): 696-702, 2023 09 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37078720
3.
Lung transplant recipients with telomere-mediated pulmonary fibrosis have increased risk for hematologic complications.
Am J Transplant
; 23(10): 1590-1602, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37392813
4.
A prospective study of the use of central venous catheters in patients newly diagnosed with acute myeloid leukemia treated with induction chemotherapy.
Support Care Cancer
; 30(2): 1673-1679, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34562168
5.
Invasive Mold Infections After Chimeric Antigen Receptor-Modified T-Cell Therapy: A Case Series, Review of the Literature, and Implications for Prophylaxis.
Clin Infect Dis
; 71(3): 672-676, 2020 07 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-31756246
6.
Hematopoietic Cell Transplantation for Paroxysmal Nocturnal Hemoglobinuria in the Age of Eculizumab.
Biol Blood Marrow Transplant
; 25(7): 1331-1339, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30711779
7.
Novel FIP1L1::KIT fusion in a myeloid neoplasm with eosinophilia, T-lymphoblastic transformation, and dasatinib response.
Haematologica
; 108(11): 3181-3185, 2023 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37102594
8.
The impact of the omission or inadequate dosing of radiotherapy in extranodal natural killer T-cell lymphoma, nasal type, in the United States.
Cancer
; 123(16): 3176-3185, 2017 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28380259
9.
Phase 1 clinical trial of adoptive immunotherapy using "off-the-shelf" activated natural killer cells in patients with refractory and relapsed acute myeloid leukemia.
Cytotherapy
; 19(10): 1225-1232, 2017 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28864289
10.
Outcomes of patients diagnosed with acute myeloid leukemia after solid organ transplantation.
Clin Transplant
; 31(9)2017 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-28710776
11.
Outcome of acute myeloid leukemia patients with pulmonary nodules of uncertain etiology receiving allogeneic hematopoietic progenitor cell transplant.
Eur J Haematol
; 96(1): 55-9, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25784319
12.
Peri-transplant clostridium difficile infections in patients undergoing allogeneic hematopoietic progenitor cell transplant.
Am J Hematol
; 91(3): 291-4, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26661725
13.
Leukapheresis in patients newly diagnosed with acute myeloid leukemia.
Transfus Apher Sci
; 55(2): 216-220, 2016 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-27470709
14.
Inferior outcome after allogeneic transplant in first remission in high-risk AML patients who required more than two cycles of induction therapy.
Am J Hematol
; 90(8): 715-8, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-26010177
15.
A Novel Integrated Approach for Cytogenomic Evaluation of Plasma Cell Neoplasms.
J Mol Diagn
; 24(10): 1067-1078, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35940519
16.
Rates and Predictors of Nonadherence to the Post-Allogeneic Hematopoietic Cell Transplantation Medical Regimen in Patients and Caregivers.
Transplant Cell Ther
; 28(3): 165.e1-165.e9, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34875403
17.
Outcomes of Patients With Acute Myeloid Leukemia Who Relapse After 5 Years of Complete Remission.
Oncol Res
; 28(7): 811-814, 2021 Sep 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32753091
18.
Prognostic significance of blast immunophenotype on first post-induction bone marrow biopsy.
Leuk Lymphoma
; 64(3): 750-752, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36722791
19.
A phase-1 study of dasatinib plus all-trans retinoic acid in acute myeloid leukemia.
Leuk Lymphoma
; 59(11): 2595-2601, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-29616864
20.
A nomogram using cytogenetics, TP53, and NPM1 mutational status can predict responses to induction chemotherapy in AML.
Leuk Lymphoma
; 63(13): 3257-3260, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36075047